A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.
作者信息
Lee Seung Ho, Kim Ji Sun, Kim Jaesang, Kim Seok Jin, Kim Won Seog, Lee Sanghyuk, Ko Young Hyeh, Yoo Hae Yong
机构信息
Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Department of Life Science, Ewha Womans University, Seoul, Korea.
出版信息
Haematologica. 2015 Dec;100(12):e505-7. doi: 10.3324/haematol.2015.133074. Epub 2015 Sep 24.
Abstract
摘要
相似文献
1
A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.
Haematologica. 2015 Dec;100(12):e505-7. doi: 10.3324/haematol.2015.133074. Epub 2015 Sep 24.
2
Evaluation of JAK2 in B and T cell neoplasms: identification of JAK2(V617F) mutation of undetermined significance (JMUS) in the bone marrow of three individuals.
Acta Haematol. 2007;118(4):209-14. doi: 10.1159/000111532. Epub 2007 Nov 21.
3
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
Nat Genet. 2014 Apr;46(4):371-5. doi: 10.1038/ng.2916. Epub 2014 Mar 2.
4
BCL10 mutations are irrelevant to its aberrant nuclear localization in nasal NK/T-cell lymphoma.
Leukemia. 2003 Nov;17(11):2240-2. doi: 10.1038/sj.leu.2403128.
5
G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.
Small GTPases. 2015;6(2):100-3. doi: 10.4161/21541248.2014.988088. Epub 2015 Jun 23.
6
A three-signal model of T-cell lymphoma pathogenesis.
Am J Hematol. 2016 Jan;91(1):113-22. doi: 10.1002/ajh.24203. Epub 2015 Nov 17.
7
Angioimmunoblastic T-cell Lymphomas With the RHOA p.Gly17Val Mutation Have Classic Clinical and Pathologic Features.
Am J Surg Pathol. 2016 Mar;40(3):335-41. doi: 10.1097/PAS.0000000000000555.
8
Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples.
Br J Haematol. 2015 Oct;171(1):145-8. doi: 10.1111/bjh.13369. Epub 2015 Mar 30.
9
[Immunophenotype analysis on neoplastic cells in bone marrow and peripheral blood of angioimmunoblastic T-cell lymphoma].
Zhonghua Bing Li Xue Za Zhi. 2009 Aug;38(8):552-4.
10
Mutational heterogeneity of angioimmunoblastic T-cell lymphoma indicates distinct lymphomagenic pathways.
Blood Cancer J. 2018 Jan 17;8(1):6. doi: 10.1038/s41408-017-0047-2.
引用本文的文献
1
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.
Am J Hematol. 2025 Sep;100(9):1486-1501. doi: 10.1002/ajh.27736. Epub 2025 Jun 13.
2
Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies.
Front Oncol. 2025 Mar 3;15:1479179. doi: 10.3389/fonc.2025.1479179. eCollection 2025.
3
New insights into the biology of T-cell lymphomas.
Blood. 2024 Oct 31;144(18):1873-1886. doi: 10.1182/blood.2023021787.
4
Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.
Clin Exp Med. 2023 Dec;23(8):4219-4235. doi: 10.1007/s10238-023-01197-9. Epub 2023 Sep 27.
5
How molecular advances may improve the diagnosis and management of PTCL patients.
Front Oncol. 2023 Jun 23;13:1202964. doi: 10.3389/fonc.2023.1202964. eCollection 2023.
6
The Interplay between T Cells and Cancer: The Basis of Immunotherapy.
Genes (Basel). 2023 Apr 28;14(5):1008. doi: 10.3390/genes14051008.
7
gain-of-function mutation drives cell-autonomous accumulation of PD-1 ICOS activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells.
Front Immunol. 2023 Mar 7;14:1095257. doi: 10.3389/fimmu.2023.1095257. eCollection 2023.
8
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma.
Cancers (Basel). 2022 Jul 29;14(15):3716. doi: 10.3390/cancers14153716.
9
Genome-Wide miRNA Expression Profiling of Molecular Subgroups of Peripheral T-cell Lymphoma.
Clin Cancer Res. 2021 Nov 1;27(21):6039-6053. doi: 10.1158/1078-0432.CCR-21-0573. Epub 2021 Aug 23.
10
Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
J Clin Exp Hematop. 2021 Jun 5;61(2):61-70. doi: 10.3960/jslrt.20059. Epub 2021 Mar 15.
本文引用的文献
1
Cutting edge: A double-mutant knockin of the CD28 YMNM and PYAP motifs reveals a critical role for the YMNM motif in regulation of T cell proliferation and Bcl-xL expression.
J Immunol. 2014 Apr 15;192(8):3465-9. doi: 10.4049/jimmunol.1301240. Epub 2014 Mar 17.
2
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
Nat Genet. 2014 Apr;46(4):371-5. doi: 10.1038/ng.2916. Epub 2014 Mar 2.
3
TET2 and DNMT3A mutations in human T-cell lymphoma.
N Engl J Med. 2012 Jan 5;366(1):95-6. doi: 10.1056/NEJMc1111708.
4
IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
Blood. 2012 Feb 23;119(8):1901-3. doi: 10.1182/blood-2011-11-391748. Epub 2012 Jan 3.
5
International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
J Clin Oncol. 2008 Sep 1;26(25):4124-30. doi: 10.1200/JCO.2008.16.4558. Epub 2008 Jul 14.
6
Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation.
J Immunol. 2006 Jul 15;177(2):1085-91. doi: 10.4049/jimmunol.177.2.1085.
7
A point mutation in CD28 distinguishes proliferative signals from survival signals.
Nat Immunol. 2001 Apr;2(4):325-32. doi: 10.1038/86327.
8
GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28.
J Immunol. 2000 Jun 1;164(11):5805-14. doi: 10.4049/jimmunol.164.11.5805.
9
Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK.
J Immunol. 1997 Jan 15;158(2):580-90.
10
CD28/B7 system of T cell costimulation.
Annu Rev Immunol. 1996;14:233-58. doi: 10.1146/annurev.immunol.14.1.233.
Zotero 插件